We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+18.11%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
10 Year Est. Return
AUM
$514M
AUM Growth
+$169M
Cap. Flow
+$103M
Cap. Flow %
19.96%
Top 10 Hldgs %
26.88%
Holding
503
New
57
Increased
239
Reduced
90
Closed
78

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$4.85M
2
ADI icon
Analog Devices
ADI
+$3.37M
3
AMZN icon
Amazon
AMZN
+$3.21M
4
LULU icon
lululemon athletica
LULU
+$2.87M
5
ORCL icon
Oracle
ORCL
+$1.91M

Sector Composition

Rank Sector Weight
1 Technology 34.39%
2 Healthcare 30.05%
3 Consumer Discretionary 17.55%
4 Communication Services 6.11%
5 Consumer Staples 4.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABOS icon
426
Acumen Pharmaceuticals
ABOS
$181M
-1,481
Closed -$6.15K
ABSI icon
427
Absci
ABSI
$1.61B
-2,383
Closed -$3.15K
ACET icon
428
Adicet Bio
ACET
$77.3M
-69
Closed -$1.51K
ADAP
429
DELISTED
Adaptimmune Therapeutics
ADAP
-5,285
Closed -$4.12K
AFMD
430
DELISTED
Affimed
AFMD
-383
Closed -$1.83K
ALLK
431
DELISTED
Allakos
ALLK
-2,225
Closed -$5.05K
ALT icon
432
Altimmune
ALT
$570M
-1,354
Closed -$3.52K
ANNX icon
433
Annexon
ANNX
$873M
-1,368
Closed -$3.23K
ATRA icon
434
Atara Biotherapeutics
ATRA
$83.1M
-104
Closed -$3.83K
BCAB icon
435
BioAtla
BCAB
$5.61M
-24
Closed -$2.07K
CCCC icon
436
C4 Therapeutics
CCCC
$480M
-1,269
Closed -$2.36K
CDXS icon
437
Codexis
CDXS
$172M
-1,790
Closed -$3.38K
CMPS
438
Compass Pathways
CMPS
$1.97B
-690
Closed -$5.11K
COHR icon
439
Coherent
COHR
$69.6B
-30,000
Closed -$979K
DSGN icon
440
Design Therapeutics
DSGN
$917M
-1,435
Closed -$3.39K
EBAY icon
441
eBay
EBAY
$45.5B
-1,983
Closed -$87.4K
EDU icon
442
New Oriental
EDU
$8.49B
-1,325
Closed -$77.6K
ENPH icon
443
Enphase Energy
ENPH
$5.39B
-508
Closed -$61K
ENTA icon
444
Enanta Pharmaceuticals
ENTA
$393M
-548
Closed -$6.12K
ESPR
445
DELISTED
Esperion Therapeutics
ESPR
-2,748
Closed -$2.69K
FATE icon
446
Fate Therapeutics
FATE
$317M
-2,526
Closed -$5.36K
KYNB
447
Kyntra Bio
KYNB
$28.7M
-101
Closed -$2.17K
FHTX icon
448
Foghorn Therapeutics
FHTX
$394M
-1,073
Closed -$5.37K
GBIO
449
DELISTED
Generation Bio
GBIO
-170
Closed -$6.42K
GLUE icon
450
Monte Rosa Therapeutics
GLUE
$1.36B
-1,280
Closed -$6.13K

Similar funds

China Universal Asset Management Company's Q4 2023 Portfolio in Review

As of Q4 2023, China Universal Asset Management Company held 503 positions worth $514M, up 49% from $345M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

China Universal Asset Management Company deployed $103M of net new capital in Q4 2023, opening 57 new positions and adding to 239 existing holdings. Its largest new stake was GSK: 54,345 shares worth $2.03M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 38% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was NVIDIA, an estimated $4.85M trimmed.

  • China Universal Asset Management Company's largest Q4 2023 buy was GSK: 54,345 shares worth $2.03M.
  • China Universal Asset Management Company added most to Vertex Pharmaceuticals in Q4 2023, an estimated $6.25M increase.
  • China Universal Asset Management Company's biggest Q4 2023 reduction was NVIDIA, cutting an estimated $4.85M.
  • China Universal Asset Management Company fully exited Oracle in Q4 2023, selling an estimated $1.91M.
  • China Universal Asset Management Company's ten largest holdings make up 27% of its $514M portfolio in Q4 2023.
  • China Universal Asset Management Company opened 57 new positions and closed 78 in Q4 2023.
  • China Universal Asset Management Company's portfolio value rose 49% quarter-over-quarter to $514M.

Based on China Universal Asset Management Company's 13F filing for Q4 2023, filed 24 Jan 2024.